Table 1.
Perturbation Method | Effect | Element(s) Targeted | Reference(s) |
---|---|---|---|
CRISPR-ko | Mutagenesis | Enhancers, protein-coding genes (PCG) | [37,38,39] |
CRISPR-ko | Transcription start site/whole sequence deletion | lncRNAs | [40,41] |
CRISPR-ko | Splice site mutation | lncRNAs | [42] |
CRISPR-ko | Tiling deletion | lncRNAs | [43] |
CRISPR-ki | Synthetic polyadenylation signal (spA) insertion | lncRNAs | [44] |
CRISPRi | Transcription inhibition | lncRNAs, enhancers, PCG | [45,46,47,48,49,50,51,52] |
CRISPRi | Epigenetic silencing | lncRNAs, enhancers, PCG | [53] |
CRISPRi | Binding site interactions | Enhancers | [50,51,52,54] |
CRISPRa | Transcription activation | lncRNAs, enhancers, PCG | [51,55,56,57,58] |
CRISPRa | Epigenetic activation | lncRNAs, enhancers, PCG | [53] |
Cas13 | RNA targeting | lncRNAs, circRNA, PCG | [59,60,61,62] |